Because they are subject to a lower regulatory standard, compounded drugs should only be distributed to health care facilities or dispensed to patients to fulfill the needs of patients whose medical needs cannot be met by an FDA-approved drug. Talk to your health care provider about compounded weight loss medications or other options Ultimately, deciding whether to use a compounded GLP-1RA is a personal choice that should involve a conversation between the patient and their prescriber
Presented for research literature review only Lichtenstein GR (2025)
If you would like a printable checklist to take to your clinician I can draft one for you
Fitzpatrick has received consulting fees from the following companies: Boehringer Ingelheim, Genentech Consulting, GlaxoSmithKline Scientific Advisory Board, MedImmune, Inc., Consulting, and Merck Scientific Advisory Board
And one of the hardest to diagnose without access to analytical chemistry tools like HPLC
This is healthy weight loss with heart, rooted in our Louisiana values